Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed Aug 3, 2021 · 10-Q · 34 days after period end · 0001683168-21-003233
| Metric | Q2 2021 | Q2 2020 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$979.42K | -$511.00 | -$351.04K | $967.02K |
| EPS Diluted | -$0.14 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 3, 2021 · 34 d after period end
